PSA
50
4
AAL
32
5
CME
45
-11
KMI
46
-2
LUV
57
3
CFG
68
8
CF
51
-2
ED
34
-3
APA
48
2
PEP
27
-3
SBUX
47
2
PEG
60
3
EW
37
-4
HOG
38
4
PNC
67
6
DHR
58
2
REGN
35
3
EA
52
2
GOOGL
56
2
LMT
60
3
PSA
50
4
AAL
32
5
CME
45
-11
KMI
46
-2
LUV
57
3
CFG
68
8
CF
51
-2
ED
34
-3
APA
48
2
PEP
27
-3
SBUX
47
2
PEG
60
3
EW
37
-4
HOG
38
4
PNC
67
6
DHR
58
2
REGN
35
3
EA
52
2
GOOGL
56
2
LMT
60
3
Financhill
Back

Apellis Pharmaceuticals Vs. United Therapeutics Industry Stock Comparison

Sell
48

APLS
Apellis Pharmaceuticals

Last Price:
$19.28
Seasonality Move:
2.19%
Buy
62

UTHR
United Therapeutics

Last Price:
$325.44
Seasonality Move:
7.46%
Sell
48
Apellis Pharmaceuticals (APLS) is a Sell

Is Apellis Pharmaceuticals a Buy, Sell or Hold?

  • The current Apellis Pharmaceuticals [APLS] share price is $19.28. The Score for APLS is 48, which is 4% below its historic median score of 50, and infers higher risk than normal.
  • APLS is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Buy
62
United Therapeutics (UTHR) is a Buy

Is United Therapeutics a Buy, Sell or Hold?

  • The current United Therapeutics [UTHR] share price is $325.82. The Score for UTHR is 62, which is 24% above its historic median score of 50, and infers lower risk than normal.
  • UTHR is currently trading in the 60-70% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.

APLS Stock Price Chart

What is Apellis Pharmaceuticals's stock price today?

  • The Apellis Pharmaceuticals share price today is $19.28
    The current trend is relatively stagnant and APLS is experiencing selling pressure, which indicates risk of future bearish movement.

UTHR Stock Price Chart

What is United Therapeutics's stock price today?

  • The United Therapeutics share price today is $325.82
    Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and UTHR is experiencing buying pressure, which is a positive indicator for future bullish movement.

APLS Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -0.04 Sell
Relative Strength Index (14 RSI): 56.31 Buy
Chaikin Money Flow: -736195 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (16.94 - 19.02) Buy
Bollinger Bands (100): (18.38 - 27.78) Sell

UTHR Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): 6 Buy
Relative Strength Index (14 RSI): 64.16 Buy
Chaikin Money Flow: 235533 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (301.34 - 319.64) Buy
Bollinger Bands (100): (294.19 - 351.45) Buy

APLS Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 18.25 Buy
20-day SMA: 17.72 Buy
50-day SMA: 18.85 Buy
200-day SMA: 27.74 Sell
8-day EMA: 18.51 Buy
20-day EMA: 18.21 Buy
50-day EMA: 19.52 Sell
200-day EMA: 27.76 Sell

UTHR Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 321.76 Buy
20-day SMA: 312.95 Buy
50-day SMA: 302.42 Buy
200-day SMA: 342.01 Sell
8-day EMA: 320.93 Buy
20-day EMA: 314.47 Buy
50-day EMA: 311.52 Buy
200-day EMA: 321.55 Buy

Apellis Pharmaceuticals Earnings Growth & APLS Earnings Dates

  • Analysts estimate an earnings decrease this quarter of $0.11 per share, an increase next quarter of $0.18 per share, a decrease this year of $0.17 per share, and an increase next year of $1.07 per share.

United Therapeutics Earnings Growth & UTHR Earnings Dates

  • Analysts estimate an earnings increase this quarter of $0.69 per share, an increase next quarter of $0.24 per share, an increase this year of $2.46 per share, and an increase next year of $1.06 per share.

Apellis Pharmaceuticals Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

United Therapeutics Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):